2025–2026 HESI Pharmacology (Pharm)
Exam Version 1 (V1) Questions and Answers
(Verified Answers) Answers
2025–2026 HESI Pharmacology (Pharm) Exam Version 1 (V1) Questions and
Answers (Verified Answers)
Section 1: Foundational Principles (Questions 1-20)
1. What is the difference between pharmacokinetics and pharmacodynamics?
Answer: Pharmacokinetics is what the body does to the drug (Absorption,
Distribution, Metabolism, Excretion). Pharmacodynamics is what the drug does to
the body, including its mechanism of action and therapeutic effects.
2. A drug with a high therapeutic index is considered:
Answer: Safer. A high therapeutic index (TI) means there is a wide margin
between the therapeutic dose and the toxic dose (e.g., TI = TD50/ED50). Drugs
like penicillin have a high TI, whereas drugs like digoxin or warfarin have a low
TI.
3. The process by which a drug is transported from the systemic circulation to
body tissues is known as:
Answer: Distribution. This is influenced by factors like blood flow, protein
binding, and lipid solubility.
4. What is the "first-pass effect"?
Answer: The first-pass effect is the metabolism of an oral drug in the liver and gut
wall before it reaches the systemic circulation. This significantly reduces the
bioavailability of the drug. Nitroglycerin is a classic example, which is why it is
given sublingually to bypass this effect.
5. A patient is taking two drugs that are both highly protein-bound. What is a
significant risk?
Answer: Drug displacement, leading to toxicity. If Drug A is displaced from
protein-binding sites by Drug B, the amount of free, active Drug A in the
, bloodstream increases sharply, potentially leading to an exaggerated effect or
toxicity.
6. Define agonist and antagonist.
Answer: An agonist is a drug that binds to a receptor and produces a functional
response (e.g., morphine is an opioid agonist). An antagonist is a drug that binds to
a receptor but blocks or inhibits a functional response (e.g., naloxone is an opioid
antagonist).
7. What does the term "half-life" (t½) of a drug mean?
Answer: The half-life is the time it takes for the plasma concentration of a drug to
be reduced by 50%. It takes approximately 5-6 half-lives for a drug to be
effectively eliminated from the body.
8. A drug that is partially metabolized in the liver and partially excreted by
the kidneys has developed toxicity in a patient with cirrhosis. Why?
Answer: The cirrhotic liver cannot effectively metabolize the drug, leading to its
accumulation in the body and subsequent toxicity. The renal excretion alone is
insufficient to clear the drug.
9. What is the primary goal of the "loading dose"?
Answer: To achieve a therapeutic plasma level of the drug rapidly. This is often
used for drugs with a long half-life where it would take too long to reach a steady
state with regular maintenance dosing (e.g., digoxin).
10. Which organ is primarily responsible for the excretion of most drugs?
Answer: The kidneys.
11. A drug with a pKa of 3.4 will be primarily in its ionized form in the
stomach (pH ~1.4). True or False?
Answer: False. According to the Henderson-Hasselbalch principle, a weak acid
(low pKa) in an acidic environment (low pH) will be predominantly non-ionized
and lipid-soluble, facilitating its absorption in the stomach.
12. What is the main difference between a side effect and an adverse effect?
Answer: A side effect is a predictable, secondary effect of a drug that may be
harmless or undesirable. An adverse effect is an unintended, harmful, and
undesirable response to a drug.
Exam Version 1 (V1) Questions and Answers
(Verified Answers) Answers
2025–2026 HESI Pharmacology (Pharm) Exam Version 1 (V1) Questions and
Answers (Verified Answers)
Section 1: Foundational Principles (Questions 1-20)
1. What is the difference between pharmacokinetics and pharmacodynamics?
Answer: Pharmacokinetics is what the body does to the drug (Absorption,
Distribution, Metabolism, Excretion). Pharmacodynamics is what the drug does to
the body, including its mechanism of action and therapeutic effects.
2. A drug with a high therapeutic index is considered:
Answer: Safer. A high therapeutic index (TI) means there is a wide margin
between the therapeutic dose and the toxic dose (e.g., TI = TD50/ED50). Drugs
like penicillin have a high TI, whereas drugs like digoxin or warfarin have a low
TI.
3. The process by which a drug is transported from the systemic circulation to
body tissues is known as:
Answer: Distribution. This is influenced by factors like blood flow, protein
binding, and lipid solubility.
4. What is the "first-pass effect"?
Answer: The first-pass effect is the metabolism of an oral drug in the liver and gut
wall before it reaches the systemic circulation. This significantly reduces the
bioavailability of the drug. Nitroglycerin is a classic example, which is why it is
given sublingually to bypass this effect.
5. A patient is taking two drugs that are both highly protein-bound. What is a
significant risk?
Answer: Drug displacement, leading to toxicity. If Drug A is displaced from
protein-binding sites by Drug B, the amount of free, active Drug A in the
, bloodstream increases sharply, potentially leading to an exaggerated effect or
toxicity.
6. Define agonist and antagonist.
Answer: An agonist is a drug that binds to a receptor and produces a functional
response (e.g., morphine is an opioid agonist). An antagonist is a drug that binds to
a receptor but blocks or inhibits a functional response (e.g., naloxone is an opioid
antagonist).
7. What does the term "half-life" (t½) of a drug mean?
Answer: The half-life is the time it takes for the plasma concentration of a drug to
be reduced by 50%. It takes approximately 5-6 half-lives for a drug to be
effectively eliminated from the body.
8. A drug that is partially metabolized in the liver and partially excreted by
the kidneys has developed toxicity in a patient with cirrhosis. Why?
Answer: The cirrhotic liver cannot effectively metabolize the drug, leading to its
accumulation in the body and subsequent toxicity. The renal excretion alone is
insufficient to clear the drug.
9. What is the primary goal of the "loading dose"?
Answer: To achieve a therapeutic plasma level of the drug rapidly. This is often
used for drugs with a long half-life where it would take too long to reach a steady
state with regular maintenance dosing (e.g., digoxin).
10. Which organ is primarily responsible for the excretion of most drugs?
Answer: The kidneys.
11. A drug with a pKa of 3.4 will be primarily in its ionized form in the
stomach (pH ~1.4). True or False?
Answer: False. According to the Henderson-Hasselbalch principle, a weak acid
(low pKa) in an acidic environment (low pH) will be predominantly non-ionized
and lipid-soluble, facilitating its absorption in the stomach.
12. What is the main difference between a side effect and an adverse effect?
Answer: A side effect is a predictable, secondary effect of a drug that may be
harmless or undesirable. An adverse effect is an unintended, harmful, and
undesirable response to a drug.
